MSR1 and metabolic dysfunction-associated steatotic liver disease: Msr1 transcript levels were found to correlate with the degree of steatosis and steatohepatitis in human NAFLD patients and a polymorphism upstream of Msr1 was strongly correlated with aspartate aminotransferase and serum triglyceride levels (Govaere et al., 2022).